“Halobetasol 0.01%/Tazarotene 0.045% (HP/TAZ) Lotion for the Treatment of Plaque Psoriasis in Patients With 3-5% Body Surface Area”, J of Skin, vol. 4, no. 6, p. s78, Oct. 2020, doi: 10.25251/skin.4.supp.78.